Cargando…

SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone

SIMPLE SUMMARY: SUMO is a ubiquitin-like post-translational modification important for many cellular processes and is suggested to play a role in cancer cell cycle progression. The aim of our study is to understand the role of SUMOylation in tumor progression and aggressiveness. Chondrosarcoma of bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kroonen, Jessie S., Kruisselbrink, Alwine B., Briaire-de Bruijn, Inge H., Olaofe, Olaejirinde O., Bovée, Judith V. M. G., Vertegaal, Alfred C. O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345166/ https://www.ncbi.nlm.nih.gov/pubmed/34359724 http://dx.doi.org/10.3390/cancers13153823

Ejemplares similares

Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma
por: Venneker, Sanne, et al.
Publicado: (2020)

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
por: Venneker, Sanne, et al.
Publicado: (2019)

Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes
por: de Jong, Yvonne, et al.
Publicado: (2019)

No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
por: Peterse, Elisabeth F. P., et al.
Publicado: (2016)

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway
por: Addie, Ruben D., et al.
Publicado: (2019)

Targeting survivin as a potential new treatment for chondrosarcoma of bone
por: de Jong, Y, et al.
Publicado: (2016)

Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma
por: Palubeckaitė, Ieva, et al.
Publicado: (2020)

A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target
por: Franceschini, Natasja, et al.
Publicado: (2021)

Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies
por: Kroonen, Jessie S., et al.
Publicado: (2023)

Mapping the SUMOylated landscape
por: Eifler, Karolin, et al.
Publicado: (2015)

Molecular mechanisms of APC/C release from spindle assembly checkpoint inhibition by APC/C SUMOylation
por: Yatskevich, Stanislau, et al.
Publicado: (2021)

Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression
por: Franceschini, Natasja, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic “Stromal” Cells from Giant Cell Tumors of Bone
por: Venneker, Sanne, et al.
Publicado: (2022)

Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
por: Peterse, Elisabeth F. P., et al.
Publicado: (2018)

IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas
por: Cleven, Arjen H. G., et al.
Publicado: (2017)

IDH Mutations in Chondrosarcoma: Case Closed or Not?
por: Venneker, Sanne, et al.
Publicado: (2023)

Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells
por: van Oosterwijk, J G, et al.
Publicado: (2013)

Histological Pattern of Endometrial Biopsies in Women with Abnormal Uterine Bleeding in a Hospital in North Central Nigeria
por: Asuzu, Ifeyinwa Mary, et al.
Publicado: (2018)

Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours
por: Cleven, Arjen H. G., et al.
Publicado: (2022)

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
por: van Oosterwijk, Jolieke G, et al.
Publicado: (2012)

Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies
por: Sha, Zhe, et al.
Publicado: (2019)

Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013
por: van Maldegem, Annemiek M, et al.
Publicado: (2014)

A review of the clinicopathologic characteristics of intestinal metaplasia in gastric mucosal biopsies
por: Olaofe, Olaejirinde Olaniyi, et al.
Publicado: (2016)

NTRK fusions are extremely rare in bone tumours
por: Lam, Suk Wai, et al.
Publicado: (2021)

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model
por: Kumar, Sumit, et al.
Publicado: (2022)

Cytokeratin 19 (CK19) expression by thyroid neoplasms in a Nigerian tertiary health centre
por: Idowu, Soremekun Ademola, et al.
Publicado: (2023)

Inhibition of mutant IDH1 decreases D-2-HG levels without affecting tumorigenic properties of chondrosarcoma cell lines
por: Suijker, Johnny, et al.
Publicado: (2015)

A screening-based approach identifies cell cycle regulators AURKA, CHK1 and PLK1 as targetable regulators of chondrosarcoma cell survival
por: de Jong, Yvonne, et al.
Publicado: (2019)

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery
por: Kumar, Ramesh, et al.
Publicado: (2017)

Uncovering Global SUMOylation Signaling Networks in a Site-Specific Manner
por: Hendriks, Ivo A., et al.
Publicado: (2014)

SENP6 regulates localization and nuclear condensation of DNA damage response proteins by group deSUMOylation
por: Claessens, Laura A., et al.
Publicado: (2023)

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option
por: Willems, Stefan M, et al.
Publicado: (2010)

Clonal Evolution through Loss of Chromosomes and Subsequent Polyploidization in Chondrosarcoma
por: Olsson, Linda, et al.
Publicado: (2011)

SUMOylation and PARylation cooperate to recruit and stabilize SLX4 at DNA damage sites
por: González-Prieto, Román, et al.
Publicado: (2015)

Correction: Clonal Evolution through Loss of Chromosomes and Subsequent Polyploidization in Chondrosarcoma
por: Olsson, Linda, et al.
Publicado: (2011)

Pattern of deaths in females in a tertiary health center, south-west Nigeria
por: Omoniyi-Esan, Olutoyin, et al.
Publicado: (2011)

Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas
por: van IJzendoorn, David G. P., et al.
Publicado: (2019)

Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma
por: Lam, Suk Wai, et al.
Publicado: (2019)

Autopsy-certified maternal mortality at Ile-Ife, Nigeria
por: Dinyain, Amatare, et al.
Publicado: (2013)

Morphological Spectrum of Orbitoocular Diseases in a Tertiary Health Centre in Keffi, North Central Nigeria
por: Onwubuya, Ifeyinwa Mary, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cfer7gqclftif2i451hp7p5b0j